Assessment of the Relationship Between Genetic Determinants of Thyroid Function and Atrial Fibrillation: A Mendelian Randomization Study.


Journal

JAMA cardiology
ISSN: 2380-6591
Titre abrégé: JAMA Cardiol
Pays: United States
ID NLM: 101676033

Informations de publication

Date de publication:
01 02 2019
Historique:
pubmed: 24 1 2019
medline: 1 2 2020
entrez: 24 1 2019
Statut: ppublish

Résumé

Increased free thyroxine (FT4) and decreased thyrotropin are associated with increased risk of atrial fibrillation (AF) in observational studies, but direct involvement is unclear. To evaluate the potential direct involvement of thyroid traits on AF. Study-level mendelian randomization (MR) included 11 studies, and summary-level MR included 55 114 AF cases and 482 295 referents, all of European ancestry. Genomewide significant variants were used as instruments for standardized FT4 and thyrotropin levels within the reference range, standardized triiodothyronine (FT3):FT4 ratio, hypothyroidism, standardized thyroid peroxidase antibody levels, and hyperthyroidism. Mendelian randomization used genetic risk scores in study-level analysis or individual single-nucleotide polymorphisms in 2-sample MR for the summary-level data. Prevalent and incident AF. The study-level analysis included 7679 individuals with AF and 49 233 referents (mean age [standard error], 62 [3] years; 15 859 men [29.7%]). In study-level random-effects meta-analysis, the pooled hazard ratio of FT4 levels (nanograms per deciliter) for incident AF was 1.55 (95% CI, 1.09-2.20; P = .02; I2 = 76%) and the pooled odds ratio (OR) for prevalent AF was 2.80 (95% CI, 1.41-5.54; P = .003; I2 = 64%) in multivariable-adjusted analyses. The FT4 genetic risk score was associated with an increase in FT4 by 0.082 SD (standard error, 0.007; P < .001) but not with incident AF (risk ratio, 0.84; 95% CI, 0.62-1.14; P = .27) or prevalent AF (OR, 1.32; 95% CI, 0.64-2.73; P = .46). Similarly, in summary-level inverse-variance weighted random-effects MR, gene-based FT4 within the reference range was not associated with AF (OR, 1.01; 95% CI, 0.89-1.14; P = .88). However, gene-based increased FT3:FT4 ratio, increased thyrotropin within the reference range, and hypothyroidism were associated with AF with inverse-variance weighted random-effects OR of 1.33 (95% CI, 1.08-1.63; P = .006), 0.88 (95% CI, 0.84-0.92; P < .001), and 0.94 (95% CI, 0.90-0.99; P = .009), respectively, and robust to tests of horizontal pleiotropy. However, the subset of hypothyroidism single-nucleotide polymorphisms involved in autoimmunity and thyroid peroxidase antibodies levels were not associated with AF. Gene-based hyperthyroidism was associated with AF with MR-Egger OR of 1.31 (95% CI, 1.05-1.63; P = .02) with evidence of horizontal pleiotropy (P = .045). Genetically increased FT3:FT4 ratio and hyperthyroidism, but not FT4 within the reference range, were associated with increased AF, and increased thyrotropin within the reference range and hypothyroidism were associated with decreased AF, supporting a pathway involving the pituitary-thyroid-cardiac axis.

Identifiants

pubmed: 30673084
pii: 2722686
doi: 10.1001/jamacardio.2018.4635
pmc: PMC6396813
doi:

Substances chimiques

Triiodothyronine 06LU7C9H1V
Thyrotropin 9002-71-5
Iodide Peroxidase EC 1.11.1.8
Thyroxine Q51BO43MG4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

144-152

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL120393
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK089174
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL120393
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL105756
Pays : United States
Organisme : American Heart Association-American Stroke Association
ID : 16EIA26410001
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL116690
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK112940
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL136852
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL134811
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Nat Commun. 2015 Mar 06;6:5681
pubmed: 25743335
Int J Endocrinol. 2018 Jun 4;2018:4836736
pubmed: 29971103
Clin Chem. 2008 Feb;54(2):249-55
pubmed: 18070814
Clin Endocrinol (Oxf). 2014 May;80(5):743-50
pubmed: 24304446
Nat Genet. 2016 Jul;48(7):709-17
pubmed: 27182965
J Clin Endocrinol Metab. 2015 May;100(5):E799-807
pubmed: 25719932
PLoS Genet. 2013;9(2):e1003266
pubmed: 23408906
Am J Hum Genet. 2011 Oct 7;89(4):529-42
pubmed: 21981779
Curr Epidemiol Rep. 2017;4(4):330-345
pubmed: 29226067
Stat Med. 2015 Sep 20;34(21):2926-40
pubmed: 25950993
Stat Med. 2017 May 20;36(11):1783-1802
pubmed: 28114746
J Am Coll Cardiol. 2007 Jan 2;49(1):71-81
pubmed: 17207725
Genet Epidemiol. 2016 May;40(4):304-14
pubmed: 27061298
Circulation. 2007 Oct 9;116(15):1725-35
pubmed: 17923583
Am J Epidemiol. 1989 Apr;129(4):687-702
pubmed: 2646917
Clin Endocrinol (Oxf). 2008 Mar;68(3):450-7
pubmed: 17941909
Ann Epidemiol. 1991 Feb;1(3):263-76
pubmed: 1669507
J Clin Endocrinol Metab. 2008 Aug;93(8):3075-81
pubmed: 18492748
PLoS Genet. 2014 Feb 27;10(2):e1004123
pubmed: 24586183
JAMA. 2006 Mar 1;295(9):1033-41
pubmed: 16507804
Nat Genet. 2018 Sep;50(9):1225-1233
pubmed: 29892015
Nat Commun. 2018 Oct 26;9(1):4455
pubmed: 30367059
Stat Med. 2008 Apr 15;27(8):1133-63
pubmed: 17886233
PLoS One. 2012;7(4):e34442
pubmed: 22493691
Behav Genet. 2017 Sep;47(5):480-485
pubmed: 28785901
BMJ. 2012 Nov 27;345:e7895
pubmed: 23186910
Nat Genet. 2017 Jun;49(6):946-952
pubmed: 28416818
Lancet. 2002 Nov 23;360(9346):1623-30
pubmed: 12457784
J Endocrinol. 2011 Jun;209(3):283-97
pubmed: 21415143
Nat Genet. 2012 Jan 22;44(3):319-22
pubmed: 22267200
Eur J Endocrinol. 2017 Jan;176(1):1-9
pubmed: 27697972
Int J Biostat. 2016 Nov 1;12(2):
pubmed: 27092657
J Am Coll Cardiol. 2015 Sep 1;66(9):1000-7
pubmed: 26314526
Circulation. 2017 Nov 28;136(22):2100-2116
pubmed: 29061566

Auteurs

Christina Ellervik (C)

Department of Laboratory Medicine, Boston Children's Hospital, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.
Division of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Carolina Roselli (C)

Program in Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.

Ingrid E Christophersen (IE)

Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
Department of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway.

Alvaro Alonso (A)

Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Maik Pietzner (M)

Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.
DZHK (German Center for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany.

Collen M Sitlani (CM)

Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle.

Stella Trompet (S)

Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
Section of Gerontology and Geriatrics, Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.

Dan E Arking (DE)

McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Bastiaan Geelhoed (B)

University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Xiuqing Guo (X)

Division of Genomic Outcomes, Institute for Translational Genomics and Population Sciences, Torrance, California.
Department of Pediatrics, Los Angeles Biomedical Research Institute, Harbor-University of California, Los Angeles Medical Center, Torrance.
Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles.

Marcus E Kleber (ME)

Vth Department of Medicine (Nephrology, Hypertensiology, Endocrinology, Diabetology, Rheumatology), Medical Faculty of Mannheim, University of Heidelberg, Mannheim, Germany.

Henry J Lin (HJ)

Division of Genomic Outcomes, Institute for Translational Genomics and Population Sciences, Torrance, California.
Department of Pediatrics, Los Angeles Biomedical Research Institute, Harbor-University of California, Los Angeles Medical Center, Torrance.
Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles.

Honghuang Lin (H)

Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
National Heart Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, Massachusetts.

Peter MacFarlane (P)

Institute of Health and Wellbeing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Elizabeth Selvin (E)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Christian Shaffer (C)

Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Albert V Smith (AV)

School of Public Health, Department of Biostatistics, University of Michigan, Ann Arbor.
Icelandic Heart Association, Kopavogur, Iceland.

Niek Verweij (N)

University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Stefan Weiss (S)

DZHK (German Center for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany.
Interfaculty Institute for Genetics and Functional Genomics, University Medicine and University Greifswald, Greifswald, Germany.

Anne R Cappola (AR)

Smilow Center for Translational Research, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Marcus Dörr (M)

DZHK (German Center for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany.
Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany.

Vilmundur Gudnason (V)

Icelandic Heart Association, Kopavogur, Iceland.
Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Susan Heckbert (S)

Department of Epidemiology, University of Washington, Seattle.

Simon Mooijaart (S)

Section of Gerontology and Geriatrics, Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Institute for Evidence-Based Medicine in Old Age, Leiden, the Netherlands.

Winfried März (W)

Vth Department of Medicine (Nephrology, Hypertensiology, Endocrinology, Diabetology, Rheumatology), Medical Faculty of Mannheim, University of Heidelberg, Mannheim, Germany.
Synlab Academy, Synlab Holding Deutschland GmbH, Mannheim, Germany.

Bruce M Psaty (BM)

Cardiovascular Health Research Unit, Department of Medicine, Epidemiology, and Health Services, University of Washington, Seattle.
Kaiser Permanente Washington Health Research Institute, Seattle.

Paul M Ridker (PM)

Harvard Medical School, Boston, Massachusetts.
Division of Cardiovascular, Brigham and Women's Hospital, Boston, Massachusetts.
Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Dan Roden (D)

Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

David J Stott (DJ)

Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Henry Völzke (H)

DZHK (German Center for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany.
Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.

Emelia J Benjamin (EJ)

Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
National Heart Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, Massachusetts.
Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts.

Graciela Delgado (G)

Vth Department of Medicine (Nephrology, Hypertensiology, Endocrinology, Diabetology, Rheumatology), Medical Faculty of Mannheim, University of Heidelberg, Mannheim, Germany.

Patrick Ellinor (P)

Harvard Medical School, Boston, Massachusetts.
Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, Massachusetts.
Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, Massachusetts.

Georg Homuth (G)

University Medicine Greifswald, Interfaculty Institute for Genetics and Functional Genomics, Greifswald, Germany.

Anna Köttgen (A)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.

Johan W Jukema (JW)

Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
Einthoven Laboratory for Experimental Vascular Medicine, LUMC, Leiden, the Netherlands.
Interuniversity Cardiology Institute of the Netherlands, Utrecht, the Netherlands.

Steven A Lubitz (SA)

Cardiovascular Research Center, Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston.

Samia Mora (S)

Harvard Medical School, Boston, Massachusetts.
Division of Cardiovascular, Brigham and Women's Hospital, Boston, Massachusetts.
Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Michiel Rienstra (M)

University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Jerome I Rotter (JI)

Division of Genomic Outcomes, Institute for Translational Genomics and Population Sciences, Torrance, California.
Department of Pediatrics, Los Angeles Biomedical Research Institute, Harbor-University of California, Los Angeles Medical Center, Torrance.
Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles.

M Benjamin Shoemaker (MB)

Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Nona Sotoodehnia (N)

Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle.

Kent D Taylor (KD)

Division of Genomic Outcomes, Institute for Translational Genomics and Population Sciences, Torrance, California.
Department of Pediatrics, Los Angeles Biomedical Research Institute, Harbor-University of California, Los Angeles Medical Center, Torrance.
Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles.

Pim van der Harst (P)

University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Christine M Albert (CM)

Harvard Medical School, Boston, Massachusetts.
Division of Cardiovascular, Brigham and Women's Hospital, Boston, Massachusetts.
Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Daniel I Chasman (DI)

Harvard Medical School, Boston, Massachusetts.
Program in Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH